A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

NCT07489885 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: D-2570 Tablet
DRUG: Placebo Tablets

Sponsor

InventisBio Co., Ltd